The Care Capital team consists of professionals with experience in all aspects of life science investment including drug development, regulatory and commercial strategy, scientific expertise, operational management and finance. The firm's partners have been responsible for the development, management and launch of drugs having over $50 billion in peak sales and bring a depth of experience and business relationships that provide tangible value to our portfolio companies and investors.